In patients with myelodysplastic syndromes response to rHuEPO and G‐CSF treatment is related to an increase of cytogenetically normal CD34+ cells
暂无分享,去创建一个
A. Cuneo | M. Porta | G. Rigolin | A. Bardi | M. Ciccone | E. Mauro | G. Castoldi | A. Rossi | C. Fraulini | A. Bugli | L. Z. Bragotti | M. D. Porta